In several publications, BCL-2 was determined to be an important promoter to regulate cancer stem cell-like behaviors in human breast cancer cells and consequently mediated multidrug (including trastuzumab) resistance of breast cancer cells [14, 26, 27]. This evidence concerns the gene BCL2 and cancer.